Analyst rating changes are affecting the stock price of Hutchmed (China) Limited, involving HSBC and Morgan Stanley, with MarketBeat tracking the information.
1 report, 1 independent
Updated Sep 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst rating changes are affecting the stock price of Hutchmed (China) Limited, involving HSBC and Morgan Stanley, with MarketBeat tracking the information.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
HSBC
British multinational bank
-
Morgan Stanley
U.S. investment bank
Related events
- Analyst rating changes are affecting stock prices involving Moelis & Company, Morgan Stanley, and Keefe, Bruyette & Woods.
- Analyst rating targets are increasing across the market, with data aggregated by various financial firms including FactSet and MarketBeat.
- Analyst rating updates are affecting market perception for Morgan Stanley and Penn Entertainment.
- Morgan Stanley and CLSA are influencing stock prices through rating upgrades and downgrades.
- Analyst reports are affecting stock ratings and targets for companies including Shake Shack, Morgan Stanley, and Citigroup.